Ins and outs of dietary phytochemicals in cancer chemoprevention

被引:253
作者
Russo, Gian Luigi [1 ]
机构
[1] CNR, Inst Food Sci, I-83100 Avellino, Italy
关键词
phytochemicals; polyphenols; antioxidant; chemoprevention; resveratrol; quercetin; diet;
D O I
10.1016/j.bcp.2007.02.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A voluminous number of evidence suggests that an increased consumption of fruit and vegetables is a relatively easy and practical strategy to reduce significantly the incidence of chronic diseases, such as cancer, cardiovascular diseases and other aging-related pathologies. This review will critically discuss the applications of chemical and dietary chemoprevention, intending the protecting effects against cancer of chemically synthesized molecules, or phytochemicals present in the regular diet. The length of chemopreventive treatments requires the administration of low doses of chemopreventive agents, to avoid toxic side effects. This poses the question, here discussed, of the bioavailability of these compounds, usually very modest. Another key issue is whether purified phytochemicals have the same protective effects, as do the whole food or mixture of foods in which these compounds are present. These aspects will be analysed at the light of the "antioxidant hypothesis" in cancer prevention and the "combination chemoprevention", both referring to the pleiotropic and synergistic effects of compounds present in the diet. Single molecules may evolve in perfect chemopreventive agents, as in the case of tamoxifen, or generate ambiguity. Resveratrol and quercetin represent two paradoxes, discussed here. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:533 / 544
页数:12
相关论文
共 78 条
[11]   Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects [J].
Chen, C ;
Kong, ANT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (06) :318-326
[12]   Dietary chemopreventive compounds and ARE/EpRE signaling [J].
Chen, C ;
Kong, ANT .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 36 (12) :1505-1516
[13]   Antioxidant intervention as a route to cancer prevention [J].
Collins, AR .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (13) :1923-1930
[14]   Commentary - How can we prevent cancer? [J].
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :10986-10988
[15]   SIRT1 stimulation by polyphenols is affected by their stability and metabolism [J].
de Boer, Vincent C. J. ;
de Goffau, Marcus C. ;
Arts, Ilja C. W. ;
Hollman, Peter C. H. ;
Keijer, Jaap .
MECHANISMS OF AGEING AND DEVELOPMENT, 2006, 127 (07) :618-627
[16]   THE CAUSES OF CANCER - QUANTITATIVE ESTIMATES OF AVOIDABLE RISKS OF CANCER IN THE UNITED-STATES TODAY [J].
DOLL, R ;
PETO, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1981, 66 (06) :1191-+
[17]   Clinical development of histone deacetylase inhibitors as anticancer agents [J].
Drummond, DC ;
Noble, CO ;
Kirpotin, DB ;
Guo, ZX ;
Scott, GK ;
Benz, CC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :495-528
[18]  
Ferry DR, 1996, CLIN CANCER RES, V2, P659
[19]   Oxidants, oxidative stress and the biology of ageing [J].
Finkel, T ;
Holbrook, NJ .
NATURE, 2000, 408 (6809) :239-247
[20]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388